Nairong Xie
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Association of Demographic, Clinical, and Environmental Factors With Disease Severity in Adult Myasthenia Gravis: A Multicenter Cross-Sectional Study.
Journal: CNS neuroscience & therapeutics
Published: July 25, 2025
Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and Safety.
Journal: CNS neuroscience & therapeutics
Published: May 24, 2025
Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia Gravis.
Journal: CNS neuroscience & therapeutics
Published: April 14, 2025
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis.
Journal: Journal of autoimmunity
Published: February 24, 2025
Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients.
Journal: Therapeutic advances in neurological disorders
Published: October 01, 2024
The Impact of COVID-19 Vaccination and Infection on the Exacerbation of Myasthenia Gravis.
Journal: Vaccines
Published: September 24, 2024
Platelet activation plays a pro-inflammatory role in myasthenia gravis.
Journal: Nature communications
Published: June 13, 2024
Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study.
Journal: QJM : monthly journal of the Association of Physicians
Published: August 23, 2023
Comparison between mono-tacrolimus and mono-glucocorticoid in the treatment of myasthenia gravis.
Journal: Annals of clinical and translational neurology
Published: October 13, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026